Conor Medsystems Second Quarter 2006 Financial Results Conference Call
July 20 2006 - 8:09PM
PR Newswire (US)
MENLO PARK, Calif., July 20 /PRNewswire-FirstCall/ -- Conor
Medsystems, Inc. (NASDAQ:CONR) today announced that its second
quarter 2006 financial results will be released Monday, July 24,
2006 after the market close and will be followed by a conference
call at 4:30 PM Eastern time. Frank Litvack, M.D., Chairman and
Chief Executive Officer, and Michael Boennighausen, Chief Financial
Officer, will discuss the company's operating and financial results
and provide updates on the company's commercialization efforts,
clinical trials, product development activities, litigation and
other business matters. To access the live audio broadcast or the
subsequent archived recording, visit the webcast section of the
company's website located at http://www.conormed.com/. Please log
on to Conor's website several minutes prior to the start of the
presentation to ensure adequate time for any software download that
may be necessary. A replay of the web cast will remain at this
location until such time as the company reports its financial
results for the third quarter of 2006. The webcast is also being
distributed through the Thomson StreetEvents Network to both
institutional and individual investors. Individual investors can
listen to the call at http://www.fulldisclosure.com/ and
institutional investors can access the call via
http://www.streetevents.com/. The dial-in number for the conference
call is 866-362-4820 in the U.S., 617-597-5345 outside the U.S.,
and the participant passcode is 26610866. About Conor Medsystems
Conor Medsystems, Inc. develops innovative controlled vascular drug
delivery technologies, and has initially focused on the development
of drug- eluting stents to treat coronary artery disease. For
further information on Conor Medsystems and controlled vascular
delivery, visit http://www.conormed.com/. Investor inquiries:
Michael Boennighausen Chief Financial Officer 650-614-4100 Media
inquiries: BCC Partners Karen L. Bergman 650-575-1509 DATASOURCE:
Conor Medsystems CONTACT: Investor inquiries: Michael
Boennighausen, Chief Financial Officer, +1-650-614-4100; Media
inquiries: BCC Partners, Karen L. Bergman, +1-650-575-1509 Web
site: http://www.conormed.com/
Copyright
Conor Medsystems (NASDAQ:CONR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Conor Medsystems (NASDAQ:CONR)
Historical Stock Chart
From Jul 2023 to Jul 2024